Carnegie Investment Counsel’s Hologic HOLX Stock Holding History

Carnegie Investment Counsel’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,476	Closed	-$716K	–	569
2026 Q1	$716K	Sell	9,476 -223,038	-96%	-$16.8M	0.01%	363
2025 Q4	$17.3M	Buy	232,514 +3,300	+1%	+$241K	0.32%	87
2025 Q3	$15.5M	Buy	229,214 +7,686	+3%	+$510K	0.29%	97
2025 Q2	$14.4M	Buy	221,528 +21,273	+11%	+$1.28M	0.29%	104
2025 Q1	$12.4M	Buy	+200,255	New	+$13.3M	0.29%	105

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carnegie Investment Counsel's HOLX Position: Q2 2026 in Review

Carnegie Investment Counsel sold out of Hologic (HOLX) in Q2 2026, closing a stake of 9,476 shares — an estimated $716K sold.

Carnegie Investment Counsel first reported a position in HOLX in Q1 2025 and held it in 5 quarters. The position peaked at $17.3M in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Carnegie Investment Counsel reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Carnegie Investment Counsel sold 9,476 Hologic shares in Q2 2026, an estimated $716K.
Carnegie Investment Counsel first reported a position in Hologic in Q1 2025 and held it in 5 quarters.
Carnegie Investment Counsel's Hologic position peaked at $17.3M in Q4 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.